drugset / Trial / NCT01105403

Exploratory Study on POL6326 in Stem Cell Mobilization

NCT01105403

Phase 2 Completed 21 enrolled Polyphor Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether POL6326 is safe and clinically active to mobilize hematopoietic stem cells followed by transplantation

Timeline

Start
2009-04
Primary completion
2014-02
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Balixafortide Peptide Intravenous

Indications